Essex Woodlands Healthcare Partners
Private equityNew York · Growth–Late Stage · 16 people tracked
Investment thesis
EW Healthcare Partners focuses on healthcare growth equity investments driven by secular tailwinds including aging populations, rising chronic disease prevalence, growing middle-class demographics, and increased adoption of innovative technologies and therapies. The firm partners with established management teams in revenue-generating healthcare companies with significant growth potential, leveraging deep domain expertise in regulatory, reimbursement, operational, and strategic matters to create value across pharmaceuticals, medtech, and tech-enabled healthcare services.
Source: firm website, verified Jul 21, 2026.
Team · 16 people
from the firm's websiteInvestments · 32 tracked
founders shown can be your intro pathFrench natural medicine company offering a portfolio of natural, science-based innovative and personalized pharmaceutical products
Electronics product development and contract manufacturing partner specializing in medical devices
Modular and mobile cleanroom and biocontainment facilities for pharmaceutical, biotech companies and hospitals
Pharmaceutical-grade human milk processing for premature babies in hospital neonatal intensive care units
Frequently asked questions
- What stage does Essex Woodlands Healthcare Partners invest at?
- Essex Woodlands Healthcare Partners invests at the Growth, Late Stage stages.
- What sectors does Essex Woodlands Healthcare Partners focus on?
- Essex Woodlands Healthcare Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Essex Woodlands Healthcare Partners located?
- Essex Woodlands Healthcare Partners is headquartered in New York, US.
- Does Essex Woodlands Healthcare Partners lead rounds?
- Essex Woodlands Healthcare Partners typically participates in rounds rather than leading them.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
EQT Life Sciences is one of Europe's largest and most experienced life sciences investors, focusing on innovative companies developing therapeutics, medical devices, diagnostics, and healthtech globally. The firm has raised approximately 3.5 billion euros across 12 private funds and 3 investment strategies over its 30-year history.
USVP is a venture capital firm with over 40 years of history across four generations of technology investing. The firm has deployed $4.7B across 542 companies, generating 97 IPOs, and combines 150 years of combined operating experience with deep expertise in enterprise software, security, consumer technology, and healthcare.